- Home
- APGE vs DAVE Comparison
APGE vs DAVE Comparison
Compare APGE & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APGE | DAVE |
|---|---|---|
| Founded | 2022 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.6B |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | APGE | DAVE |
|---|---|---|
| Price | $134.97 | $380.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | $109.67 | ★ $312.75 |
| AVG Volume (30 Days) | ★ 1.2M | 397.4K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 222.91 |
| EPS | N/A | ★ 4.60 |
| Revenue | N/A | ★ $554,182,000.00 |
| Revenue This Year | N/A | $26.28 |
| Revenue Next Year | N/A | $17.38 |
| P/E Ratio | ★ N/A | $81.31 |
| Revenue Growth | N/A | ★ 59.67 |
| 52 Week Low | $35.39 | $152.21 |
| 52 Week High | $134.99 | $458.25 |
Technical Indicators
Market Signals| Indicator | APGE | DAVE |
|---|---|---|
| Relative Strength Index (RSI) | 77.86 | 55.97 |
| Support Level | $134.03 | $219.90 |
| Resistance Level | N/A | $438.23 |
| Average True Range (ATR) | 0.13 | 18.89 |
| MACD | -0.49 | 4.69 |
| Stochastic Oscillator | 93.56 | 88.35 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, short-term liquidity, fee-free banking, and financial management tools, and finding side gigs.